logo
Breadcrumbs Image

Lung Cancer Molecular Diagnostics Market

Lung Cancer Molecular Diagnostics Market

Global Lung Cancer Molecular Diagnostics Industry Research Report 2021 Segmented by Major Market Players, Types, Applications and Countries Forecast to 2027


Date: May-2021 | Id: MACRC-68456 | Geographical Scope: Global | Publisher: Mnemonics Research

The global Lung Cancer Molecular Diagnostics market is expected to reach US$ XX Million by 2027, with a CAGR of XX% from 2020 to 2027, based on Mnemonics Research newly published report.
 The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
 
 By Market Verdors:
 Foundationmedicine
 Sansure
 Liferiver
 Roche
 Gpmedical
 Qiagen
 Mole
 Genetech
 Tellgen
 Amoydx
 Annoroad
 
 By Types:
 PCR
 FISH
 DNA Sequencing
 Gene Chip
 
 By Applications:
 Clinical Diagnosis
 Drug Screening
 Research
 
 Key Indicators Analysed
 Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
 Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
 Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
 Opportunities and <b>Drivers:</b> Identifying the Growing Demands and New Technology
 Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
 
 Key Reasons to Purchase
 To gain insightful analyses of the market and have comprehensive understanding of the global  market and its commercial landscape.
 Assess the production processes, major issues, and solutions to mitigate the development risk.
 To understand the most affecting driving and restraining forces in the market and its impact in the global market.
 Learn about the market strategies that are being adopted by leading respective organizations.
 To understand the future outlook and prospects for the market.
 Besides the standard structure reports, we also provide custom research according to specific requirements.

Get Started with Request an Overview
Get Started with Download Brochure
Get Started with Request Methodology
Get Started with Share Customization
Get Started with Submit RFP
1 Report Overview
 1.1 Study Scope and Definition
 1.2 Research Methodology
 1.2.1 Methodology/Research Approach
 1.2.2 Data Source
 1.3 Key Market Segments
 1.4 Players Covered: Ranking by Lung Cancer Molecular Diagnostics Revenue
 1.5 Market Analysis by Type
 1.5.1 Global Lung Cancer Molecular Diagnostics Market Size Growth Rate by Type: 2021 VS 2027
 1.5.2 PCR
 1.5.3 FISH
 1.5.4 DNA Sequencing
 1.5.5 Gene Chip
 1.6 Market by Application
 1.6.1 Global Lung Cancer Molecular Diagnostics Market Share by Application: 2022-2027
 1.6.2 Clinical Diagnosis
 1.6.3 Drug Screening
 1.6.4 Research
 1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
 1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2021 and 2022 Projections
 1.7.2 Covid-19 Impact: Commodity Prices Indices
 1.7.3 Covid-19 Impact: Global Major Government Policy
 1.8 Study Objectives
 1.9 Years Considered
 2 Global Lung Cancer Molecular Diagnostics Market Trends and Growth Strategy
 2.1 Market Top Trends
 2.2 Market Drivers
 2.3 Market Challenges
 2.4 Porter’s Five Forces Analysis
 2.5 Market Growth Strategy
 2.6 SWOT Analysis
 3 Global Lung Cancer Molecular Diagnostics Market Players Profiles
 3.1 Foundationmedicine
 3.1.1 Foundationmedicine Company Profile
 3.1.2 Foundationmedicine Lung Cancer Molecular Diagnostics Product Specification
 3.1.3 Foundationmedicine Lung Cancer Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.2 Sansure
 3.2.1 Sansure Company Profile
 3.2.2 Sansure Lung Cancer Molecular Diagnostics Product Specification
 3.2.3 Sansure Lung Cancer Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.3 Liferiver
 3.3.1 Liferiver Company Profile
 3.3.2 Liferiver Lung Cancer Molecular Diagnostics Product Specification
 3.3.3 Liferiver Lung Cancer Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.4 Roche
 3.4.1 Roche Company Profile
 3.4.2 Roche Lung Cancer Molecular Diagnostics Product Specification
 3.4.3 Roche Lung Cancer Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.5 Gpmedical
 3.5.1 Gpmedical Company Profile
 3.5.2 Gpmedical Lung Cancer Molecular Diagnostics Product Specification
 3.5.3 Gpmedical Lung Cancer Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.6 Qiagen
 3.6.1 Qiagen Company Profile
 3.6.2 Qiagen Lung Cancer Molecular Diagnostics Product Specification
 3.6.3 Qiagen Lung Cancer Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.7 Mole
 3.7.1 Mole Company Profile
 3.7.2 Mole Lung Cancer Molecular Diagnostics Product Specification
 3.7.3 Mole Lung Cancer Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.8 Genetech
 3.8.1 Genetech Company Profile
 3.8.2 Genetech Lung Cancer Molecular Diagnostics Product Specification
 3.8.3 Genetech Lung Cancer Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.9 Tellgen
 3.9.1 Tellgen Company Profile
 3.9.2 Tellgen Lung Cancer Molecular Diagnostics Product Specification
 3.9.3 Tellgen Lung Cancer Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.10 Amoydx
 3.10.1 Amoydx Company Profile
 3.10.2 Amoydx Lung Cancer Molecular Diagnostics Product Specification
 3.10.3 Amoydx Lung Cancer Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.11 Annoroad
 3.11.1 Annoroad Company Profile
 3.11.2 Annoroad Lung Cancer Molecular Diagnostics Product Specification
 3.11.3 Annoroad Lung Cancer Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 4 Global Lung Cancer Molecular Diagnostics Market Competition by Market Players
 4.1 Global Lung Cancer Molecular Diagnostics Production Capacity Market Share by Market Players (2016-2021)
 4.2 Global Lung Cancer Molecular Diagnostics Revenue Market Share by Market Players (2016-2021)
 4.3 Global Lung Cancer Molecular Diagnostics Average Price by Market Players (2016-2021)
 5 Global Lung Cancer Molecular Diagnostics Production by Regions (2016-2021)
 5.1 North America
 5.1.1 North America Lung Cancer Molecular Diagnostics Market Size (2016-2021)
 5.1.2 Lung Cancer Molecular Diagnostics Key Players in North America (2016-2021)
 5.1.3 North America Lung Cancer Molecular Diagnostics Market Size by Type (2016-2021)
 5.1.4 North America Lung Cancer Molecular Diagnostics Market Size by Application (2016-2021)
 5.2 East Asia
 5.2.1 East Asia Lung Cancer Molecular Diagnostics Market Size (2016-2021)
 5.2.2 Lung Cancer Molecular Diagnostics Key Players in East Asia (2016-2021)
 5.2.3 East Asia Lung Cancer Molecular Diagnostics Market Size by Type (2016-2021)
 5.2.4 East Asia Lung Cancer Molecular Diagnostics Market Size by Application (2016-2021)
 5.3 Europe
 5.3.1 Europe Lung Cancer Molecular Diagnostics Market Size (2016-2021)
 5.3.2 Lung Cancer Molecular Diagnostics Key Players in Europe (2016-2021)
 5.3.3 Europe Lung Cancer Molecular Diagnostics Market Size by Type (2016-2021)
 5.3.4 Europe Lung Cancer Molecular Diagnostics Market Size by Application (2016-2021)
 5.4 South Asia
 5.4.1 South Asia Lung Cancer Molecular Diagnostics Market Size (2016-2021)
 5.4.2 Lung Cancer Molecular Diagnostics Key Players in South Asia (2016-2021)
 5.4.3 South Asia Lung Cancer Molecular Diagnostics Market Size by Type (2016-2021)
 5.4.4 South Asia Lung Cancer Molecular Diagnostics Market Size by Application (2016-2021)
 5.5 Southeast Asia
 5.5.1 Southeast Asia Lung Cancer Molecular Diagnostics Market Size (2016-2021)
 5.5.2 Lung Cancer Molecular Diagnostics Key Players in Southeast Asia (2016-2021)
 5.5.3 Southeast Asia Lung Cancer Molecular Diagnostics Market Size by Type (2016-2021)
 5.5.4 Southeast Asia Lung Cancer Molecular Diagnostics Market Size by Application (2016-2021)
 5.6 Middle East
 5.6.1 Middle East Lung Cancer Molecular Diagnostics Market Size (2016-2021)
 5.6.2 Lung Cancer Molecular Diagnostics Key Players in Middle East (2016-2021)
 5.6.3 Middle East Lung Cancer Molecular Diagnostics Market Size by Type (2016-2021)
 5.6.4 Middle East Lung Cancer Molecular Diagnostics Market Size by Application (2016-2021)
 5.7 Africa
 5.7.1 Africa Lung Cancer Molecular Diagnostics Market Size (2016-2021)
 5.7.2 Lung Cancer Molecular Diagnostics Key Players in Africa (2016-2021)
 5.7.3 Africa Lung Cancer Molecular Diagnostics Market Size by Type (2016-2021)
 5.7.4 Africa Lung Cancer Molecular Diagnostics Market Size by Application (2016-2021)
 5.8 Oceania
 5.8.1 Oceania Lung Cancer Molecular Diagnostics Market Size (2016-2021)
 5.8.2 Lung Cancer Molecular Diagnostics Key Players in Oceania (2016-2021)
 5.8.3 Oceania Lung Cancer Molecular Diagnostics Market Size by Type (2016-2021)
 5.8.4 Oceania Lung Cancer Molecular Diagnostics Market Size by Application (2016-2021)
 5.9 South America
 5.9.1 South America Lung Cancer Molecular Diagnostics Market Size (2016-2021)
 5.9.2 Lung Cancer Molecular Diagnostics Key Players in South America (2016-2021)
 5.9.3 South America Lung Cancer Molecular Diagnostics Market Size by Type (2016-2021)
 5.9.4 South America Lung Cancer Molecular Diagnostics Market Size by Application (2016-2021)
 5.10 Rest of the World
 5.10.1 Rest of the World Lung Cancer Molecular Diagnostics Market Size (2016-2021)
 5.10.2 Lung Cancer Molecular Diagnostics Key Players in Rest of the World (2016-2021)
 5.10.3 Rest of the World Lung Cancer Molecular Diagnostics Market Size by Type (2016-2021)
 5.10.4 Rest of the World Lung Cancer Molecular Diagnostics Market Size by Application (2016-2021)
 6 Global Lung Cancer Molecular Diagnostics Consumption by Region (2016-2021)
 6.1 North America
 6.1.1 North America Lung Cancer Molecular Diagnostics Consumption by Countries
 6.1.2 United States
 6.1.3 Canada
 6.1.4 Mexico
 6.2 East Asia
 6.2.1 East Asia Lung Cancer Molecular Diagnostics Consumption by Countries
 6.2.2 China
 6.2.3 Japan
 6.2.4 South Korea
 6.3 Europe
 6.3.1 Europe Lung Cancer Molecular Diagnostics Consumption by Countries
 6.3.2 Germany
 6.3.3 United Kingdom
 6.3.4 France
 6.3.5 Italy
 6.3.6 Russia
 6.3.7 Spain
 6.3.8 Netherlands
 6.3.9 Switzerland
 6.3.10 Poland
 6.4 South Asia
 6.4.1 South Asia Lung Cancer Molecular Diagnostics Consumption by Countries
 6.4.2 India
 6.5 Southeast Asia
 6.5.1 Southeast Asia Lung Cancer Molecular Diagnostics Consumption by Countries
 6.5.2 Indonesia
 6.5.3 Thailand
 6.5.4 Singapore
 6.5.5 Malaysia
 6.5.6 Philippines
 6.6 Middle East
 6.6.1 Middle East Lung Cancer Molecular Diagnostics Consumption by Countries
 6.6.2 Turkey
 6.6.3 Saudi Arabia
 6.6.4 Iran
 6.6.5 United Arab Emirates
 6.7 Africa
 6.7.1 Africa Lung Cancer Molecular Diagnostics Consumption by Countries
 6.7.2 Nigeria
 6.7.3 South Africa
 6.8 Oceania
 6.8.1 Oceania Lung Cancer Molecular Diagnostics Consumption by Countries
 6.8.2 Australia
 6.9 South America
 6.9.1 South America Lung Cancer Molecular Diagnostics Consumption by Countries
 6.9.2 Brazil
 6.9.3 Argentina
 6.10 Rest of the World
 6.10.1 Rest of the World Lung Cancer Molecular Diagnostics Consumption by Countries
 7 Global Lung Cancer Molecular Diagnostics Production Forecast by Regions (2022-2027)
 7.1 Global Forecasted Production of Lung Cancer Molecular Diagnostics (2022-2027)
 7.2 Global Forecasted Revenue of Lung Cancer Molecular Diagnostics (2022-2027)
 7.3 Global Forecasted Price of Lung Cancer Molecular Diagnostics (2022-2027)
 7.4 Global Forecasted Production of Lung Cancer Molecular Diagnostics by Region (2022-2027)
 7.4.1 North America Lung Cancer Molecular Diagnostics Production, Revenue Forecast (2022-2027)
 7.4.2 East Asia Lung Cancer Molecular Diagnostics Production, Revenue Forecast (2022-2027)
 7.4.3 Europe Lung Cancer Molecular Diagnostics Production, Revenue Forecast (2022-2027)
 7.4.4 South Asia Lung Cancer Molecular Diagnostics Production, Revenue Forecast (2022-2027)
 7.4.5 Southeast Asia Lung Cancer Molecular Diagnostics Production, Revenue Forecast (2022-2027)
 7.4.6 Middle East Lung Cancer Molecular Diagnostics Production, Revenue Forecast (2022-2027)
 7.4.7 Africa Lung Cancer Molecular Diagnostics Production, Revenue Forecast (2022-2027)
 7.4.8 Oceania Lung Cancer Molecular Diagnostics Production, Revenue Forecast (2022-2027)
 7.4.9 South America Lung Cancer Molecular Diagnostics Production, Revenue Forecast (2022-2027)
 7.4.10 Rest of the World Lung Cancer Molecular Diagnostics Production, Revenue Forecast (2022-2027)
 7.5 Forecast by Type and by Application (2022-2027)
 7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)
 7.5.2 Global Forecasted Consumption of Lung Cancer Molecular Diagnostics by Application (2022-2027)
 8 Global Lung Cancer Molecular Diagnostics Consumption Forecast by Regions (2022-2027)
 8.1 North America Forecasted Consumption of Lung Cancer Molecular Diagnostics by Country
 8.2 East Asia Market Forecasted Consumption of Lung Cancer Molecular Diagnostics by Country
 8.3 Europe Market Forecasted Consumption of Lung Cancer Molecular Diagnostics by Countriy
 8.4 South Asia Forecasted Consumption of Lung Cancer Molecular Diagnostics by Country
 8.5 Southeast Asia Forecasted Consumption of Lung Cancer Molecular Diagnostics by Country
 8.6 Middle East Forecasted Consumption of Lung Cancer Molecular Diagnostics by Country
 8.7 Africa Forecasted Consumption of Lung Cancer Molecular Diagnostics by Country
 8.8 Oceania Forecasted Consumption of Lung Cancer Molecular Diagnostics by Country
 8.9 South America Forecasted Consumption of Lung Cancer Molecular Diagnostics by Country
 8.10 Rest of the world Forecasted Consumption of Lung Cancer Molecular Diagnostics by Country
 9 Global Lung Cancer Molecular Diagnostics Sales by Type (2016-2027)
 9.1 Global Lung Cancer Molecular Diagnostics Historic Market Size by Type (2016-2021)
 9.2 Global Lung Cancer Molecular Diagnostics Forecasted Market Size by Type (2022-2027)
 10 Global Lung Cancer Molecular Diagnostics Consumption by Application (2016-2027)
 10.1 Global Lung Cancer Molecular Diagnostics Historic Market Size by Application (2016-2021)
 10.2 Global Lung Cancer Molecular Diagnostics Forecasted Market Size by Application (2022-2027)
 11 Global Lung Cancer Molecular Diagnostics Manufacturing Cost Analysis
 11.1 Lung Cancer Molecular Diagnostics Key Raw Materials Analysis
 11.1.1 Key Raw Materials
 11.2 Proportion of Manufacturing Cost Structure
 11.3 Manufacturing Process Analysis of Lung Cancer Molecular Diagnostics
 12 Global Lung Cancer Molecular Diagnostics Marketing Channel, Distributors, Customers and Supply Chain
 12.1 Marketing Channel
 12.2 Lung Cancer Molecular Diagnostics Distributors List
 12.3 Lung Cancer Molecular Diagnostics Customers
 12.4 Lung Cancer Molecular Diagnostics Supply Chain Analysis
 13 Analyst's Viewpoints/Conclusions
 14 Disclaimer

Add to Cart

Single User

$ 2450.00

Site License

$ 3675.00

Enterprisewide

$ 4900.00